Principal Securities Inc. boosted its position in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Free Report) by 23.7% in ...

Zimmer Biomet Holdings (NYSE:ZBH) has had a rough month with its share price down 5.4%. However, stock prices are usually driven by a company’s financials over the long term, which in this case look ...

Principal Financial Group Inc. lowered its stake in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Free Report) by 4.0% ...

Zimmer Biomet is suffering due to macroeconomic uncertainties, pricing pressure and unfavorable currency fluctuations.

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products ...

Investors in Zimmer Biomet Holdings Inc (Symbol: ZBH) saw new options begin trading today, for the March 2026 expiration. One of the key data points that goes into the price an option buyer is ...

In a report released today, Ryan Zimmerman from BTIG maintained a Buy rating on Zimmer Biomet Holdings (ZBH – Research Report), with a price ...

In a report released today, Caitlin Cronin from Canaccord Genuity maintained a Hold rating on Zimmer Biomet Holdings (ZBH – Research Report), with a price target of $115.00. The company’s ...

Although the revenue and EPS for Zimmer (ZBH) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street ...